Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/9700
Title: Single and serial measurements of cardiac troponin I in asymptomatic patients on chronic hemodialysis.
Authors: Roberts, Matthew A;Fernando, D;Macmillan, N;Proimos, G;Bach, Leon A;Power, David Anthony;Ratnaike, S;Ierino, F L
Affiliation: Department of Nephrology, Austin Health, Heidelberg, Victoria, Australia.
Issue Date: 1-Jan-2004
Citation: Clinical Nephrology; 61(1): 40-6
Abstract: Coronary artery disease is the major cause of death in patients with end-stage renal failure on dialysis. This study aimed to assess the predictive value of a single cardiac troponin I (cTnI), and also the kinetics of serial values.Since cTnI is a potential biomarker of cardiac outcome, the present study examined single cTnI measurements (n = 88 patients) and its predictive value for future cardiac events, and a kinetic substudy of serial weekly cTnI measured for 8 weeks (n = 57) in a group of patients on hemodialysis.Single cTnI measurements: 9 patients (10.2%) had a detectable cTnI at baseline and 79 patients (89.8%) had a negative baseline cTnI. There were no significant differences in age, sex, history of ischemic heart disease, diabetes, smoking or dyslipidemia between patients with detectable and negative cTnI. At the end of 9 months, the rate of combined primary endpoints, which included myocardial infarction, cardiac death and cardiac revascularization, was significantly higher in the patients with a detectable baseline cTnI (55.6%), compared to patients with a negative cTnI (6.3%) (p = 0.0007). Serial weekly cTnI measurements: significant fluctuations in cTnI were noted over time; 27% of patients with an undetectable cTnI measured at baseline had subsequent detectable levels in the serial follow-up.A single detectable cTnI in asymptomatic patients on hemodialysis defines patients at high risk of future cardiac events. However, the incidence of detectable cTnI levels is markedly increased when serial weekly measurements are performed. The clinical significance of detectable serial measurements of cTnI is the focus of ongoing studies.
Internal ID Number: 14964456
URI: http://ahro.austin.org.au/austinjspui/handle/1/9700
URL: http://www.ncbi.nlm.nih.gov/pubmed/14964456
Type: Journal Article
Subjects: Coronary Artery Disease.diagnosis.etiology
Female
Humans
Male
Middle Aged
Predictive Value of Tests
Renal Dialysis.adverse effects
Troponin I.analysis
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.